MENU
+Compare
ACHV
Stock ticker: NASDAQ
AS OF
Jun 18, 04:59 PM (EDT)
Price
$3.15
Change
+$0.17 (+5.70%)
Capitalization
108.91M

ACHV Achieve Life Sciences Forecast, Technical & Fundamental Analysis

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction... Show more

Industry: #Biotechnology
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ACHV with price predictions
Jun 17, 2025

ACHV in upward trend: 10-day moving average broke above 50-day moving average on May 16, 2025

The 10-day moving average for ACHV crossed bullishly above the 50-day moving average on May 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

ACHV moved above its 50-day moving average on May 15, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ACHV advanced for three days, in of 253 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 164 cases where ACHV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ACHV moved out of overbought territory on June 04, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ACHV as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ACHV turned negative on June 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACHV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACHV broke above its upper Bollinger Band on June 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACHV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.060) is normal, around the industry mean (16.947). P/E Ratio (0.000) is within average values for comparable stocks, (59.391). ACHV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.290). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (257.499).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACHV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACHV is expected to report earnings to fall 8.89% to -33 cents per share on August 07

Achieve Life Sciences ACHV Stock Earnings Reports
Q2'25
Est.
$-0.34
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.02
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.01
The last earnings report on May 13 showed earnings per share of -37 cents, beating the estimate of -37 cents. With 204.53K shares outstanding, the current market capitalization sits at 108.91M.
A.I. Advisor
published General Information

General Information

a developer of specialty pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
22722 29th Dr. SE
Phone
+1 425 686-1500
Employees
22
Web
https://www.achievelifesciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMRRY14.100.38
+2.77%
B&M European Value Retail SA
BHKLY88.12-0.61
-0.69%
BOC Hong Kong (Holdings) Ltd.
ASMLF761.15-8.36
-1.09%
ASML Holding N.V.
NVZMY73.95-1.28
-1.70%
NOVONESIS A S
ARRNF0.18-0.01
-3.22%
American Rare Earths Ltd.

ACHV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ABOS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-3.87%
ABOS - ACHV
43%
Loosely correlated
+7.02%
EYPT - ACHV
42%
Loosely correlated
-1.01%
AXSM - ACHV
41%
Loosely correlated
-0.09%
ATOS - ACHV
40%
Loosely correlated
-4.77%
PDSB - ACHV
40%
Loosely correlated
-8.99%
More